Navigation Links
New Zeus Biomimetic Coated PICC Now Available
Date:8/26/2009

r4 Vascular announces the commercial availability of the new Zeus™ Coated CT Peripherally-inserted Central Catheter (PICC). A novel coating on the catheter surface mimics the glycocalyx layer found on natural endothelial tissue surfaces in vessel walls. Laboratory tests prove that mimicking the glycocalyx layer can dramatically reduce thrombus formation on the internal and external surface of the catheter.

Maple Grove, MN (Vocus) August 26, 2009 -- r4 Vascular announces the commercial availability of the new Zeus™ Coated CT Peripherally-inserted Central Catheter (PICC). A novel coating on the catheter surface mimics the glycocalyx layer found on natural endothelial tissue surfaces in vessel walls. Laboratory tests prove that mimicking the glycocalyx layer can dramatically reduce thrombus formation on the internal and external surface of the catheter.

According to Gail Sansivero, MS, ANP, Vascular and Interventional Radiology Nurse Practitioner, Albany Medical Center, "Thrombus can be a real problem for patients with PICCs. Biologically, a patient responds to a catheter insertion within 24 hours by developing bio-film, leading to thrombus that can cause catheter occlusion, infection, or dislodge into the bloodstream."

Developing the catheter, r4 Vascular engineers took a cue from stealth coating technologies, approaching the thrombus problem by camouflaging the catheter in a biomimetic coating. Laboratory testing has shown the coating to be so effective that the Zeus™ Coated CT Catheter is the first non-valved PICC to receive FDA clearance for saline-only maintenance.

The Zeus™ Coated CT PICC is one of several keynote technologically-advanced catheter systems from r4 Vascular. r4 Vascular marks its entry into the vascular access marketplace with the Zeus™ Coated CT PICC, and the Pegasus™ Uncoated CT PICC. The two catheters will debut at the 23rd Annual Scientific Meeting of the Association for Vascular Access, being held September 15-17, 2009 in Las Vegas, NV. A new drainage catheter designed for easier placement and exchange is also now available from r4 Vascular.

According to r4 Vascular President, Donald Geer, "r4 Vascular's commitment is to save hospitals money and improve patient care, consequently we launched the Zeus Coated CT PICC to reduce thrombus complications and their related expenses; but we also recognize that not all patients will be exposed to the complications that our biomimetic coating was designed to reduce, so we launched our uncoated Pegasus PICC for patients that may not require a coated catheter."

r4 Vascular is a privately-held vascular access company driving innovation in vascular access medical technology. r4's passion is "uncomplicating" venous access, chemotherapy, and drug delivery, through product improvements that help catheters remain patent and effective, with reduced risk of complications.

# # #

Read the full story at http://www.prweb.com/releases/biomimetic_coating/coated_PICC/prweb2792954.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. DNA-coated nanotubes help kill tumors without harm to surrounding tissue
2. New ACTICOAT(TM) Silver Coated Anti-microbial Barrier Dressing Receives 510(k) Clearance from the US FDA
3. Watson Pharmaceuticals Receives FDA Approval for Fruit and Cinnamon Flavored Coated Nicotine Gums
4. Newest Coated Stent Does Well in Real-World Trial
5. Cardiva Medical, Inc. Receives FDA Clearance for the Catalyst(TM)III System, First in Class Drug Coated Vessel Closure Device
6. Drug-Coated Stents Better at Keeping Arteries Open
7. Drug-Coated Sponges May Limit Catheter Infections
8. UT Southwestern researchers find drug-coated stents less risky for heart bypass patients
9. Watson Pharmaceuticals Receives FDA Approval for Mint Coated Nicotine Gum
10. Coated Stents Better Than Bare Metal Ones in Short Run
11. Coated Stents Best for Heart Patients With Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Zeus Biomimetic Coated PICC Now Available
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the air at King ... colors, assortments and packaging. This staple for Valentine’s Day is a must-have, and can ... For Valentine’s Day, not only are long-stem roses available, but also other flower bouquets, ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... stage for new clinical and scientific initiatives have all marked the last 12 ... appointed President and CEO of the nation’s oldest cancer center, Candace S. Johnson, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Francisco ... micro-needling services in their Napa Valley office. The technique utilizes the body’s own ... Dr. Canales and Dr. Furnas, are part of only a select few cosmetic ...
(Date:2/5/2016)... ... ... After years as an active staff surgeon and having served as the director ... transitioned to chief of the Division of Plastic Surgery at what is now known ... began a second three-year term in January of 2016. , The original selection was ...
(Date:2/5/2016)... ... February 05, 2016 , ... In the fourth quarter ... gathered at the La Valencia Hotel in San Diego, California to discuss changes ... the year’s most outstanding franchise, walking away with the coveted David Wright Award ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... India , February 5, 2016 ... a new market research report "Fetal (Labor & Delivery) ... & Antepartum), Warmer, Incubator, Pulse Oximeter, Phototherapy/Jaundice Management Devices, ... published by MarketsandMarkets, This report studies the global market ... market is estimated at USD 6.28 Billion in 2015 ...
(Date:2/4/2016)... 2016 For hospitals considering enrollment in the ... in the program, the Health Resources and Services Administration,s ... , Mega-Guidance , could have significant impact on plans ... September 2016. Essential Insights , Daniel ... summarizes the Mega-Guidance,s key proposed changes, including a new ...
(Date:2/4/2016)... , Feb. 4, 2016  SciClone Pharmaceuticals, ... announced it has entered into a settlement agreement ... (SEC) fully resolving the SEC,s investigation into possible ... Under the terms of the settlement agreement, SciClone ... million, including disgorgement, pre-judgment interest and a penalty.  ...
Breaking Medicine Technology: